Frederick C. Kull

3.5k citations

39 papers · 2.7k indexed · 1 hit paper · h-index 20

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Growth Hormone and Insulin-like Growth Factors
Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Muscle Physiology and Disorders
- Glycosylation and Glycoproteins Research

Papers in

Radiology, Nuclear Medicine and Imaging 10
- Monoclonal and Polyclonal Antibodies Research 8
- Radiopharmaceutical Chemistry and Applications 4
Endocrinology, Diabetes and Metabolism 7
- Growth Hormone and Insulin-like Growth Factors 3

Co-authors: Pedro Cuatrecasas Steven Jacobs Judson J. Van Wyk Y F Su H. Shelton Earp Julie B. Stimmel Shalender Bhasin Wayne E. Taylor
Journals: Proceedings of the National Academy of Sciences (5 papers)Experimental Biology and Medicine (4 papers)Journal of Biological Chemistry (4 papers)Biochemical and Biophysical Research Communications (3 papers)Journal of Cellular Biochemistry (2 papers)
Partner nations: United States Netherlands India

In The Last Decade

Frederick C. Kull

37 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Monoclonal antibodies to receptors for insulin and somatomedin-C. 1983 · 383 citations

Peers

Countries citing papers authored by Frederick C. Kull

Since Specialization

Citations

This map shows the geographic impact of Frederick C. Kull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick C. Kull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick C. Kull more than expected).

Fields of papers citing papers by Frederick C. Kull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick C. Kull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick C. Kull. The network helps show where Frederick C. Kull may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frederick C. Kull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick C. Kull Line = papers co-authored together Frederick C. Kull links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Differential levels of “urotensin-II-like” activity determined by radio-receptor and radioimmuno-assays Peptides ·Nambi Aiyar, B.O. Ríos Velázquez, Zhaohui Ao, Jyoti Disa, Diane P. Naselsky, David J. Behm, Jui‐Lan Su, Frederick C. Kull, Stephen A. Douglas	2004	17
2	A cell-based time-resolved fluorescence assay for selection of antibody reagents for G protein-coupled receptor immunohistochemistry Journal of Immunological Methods ·Jui‐Lan Su, Mohammad Baharuddin, 华辰银, Susan M. Goldsworthy, Fathmasari Fitrianingsih, Surbhi Chhabra, Chris Plumpton, J. N. Silva, Michael A. Romanos, Thomas A. Kost, Frederick C. Kull	2004	8
3	Production and Characterization of Monoclonal Antibodies against the Vasoconstrictive Peptide Human Urotensin-II PubMed ·Jui‐Lan Su, Zhaohui Ao, Nambi Aiyar, Byron Ellis, John D. Martin, Stephen A. Douglas, Frederick C. Kull	2003	5
4	Myostatin inhibits cell proliferation and protein synthesis in C₂C₁₂ muscle cells American Journal of Physiology-Endocrinology and Metabolism ·Wayne E. Taylor, Shalender Bhasin, Jorge Artaza, André Miguel, M Azam, R Suenaga, Frederick C. Kull, Néstor F. González-Cadavid	2001	342
5	Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies Journal of Biological Chemistry ·Julie B. Stimmel, B M Merrill, Lee F. Kuyper, Carlos Daniel Ramírez Amaya, Jeff Hutchins, Mary E. Fling, Frederick C. Kull	2000	55
6	Development of Class-Switched, Affinity-Matured Monoclonal Antibodies Following a 7-Day Immunization Schedule Hybridoma ·Jane M. Bynum, John L. Andrews, BYRON ELLIS, Frederick C. Kull, Elizabeth A. Austin, Milena Szczepańska	1999	11
7	Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo Journal of Cellular Biochemistry ·Farah Zia, Daniele Ottolina, Frederick C. Kull, Frank Cuttitta, James L. Mulshine, Terry W. Moody	1996	42
8	Yttrium-90 Chelation Properties of Tetraazatetraacetic Acid Macrocycles, Diethylenetriaminepentaacetic Acid Analogs, and a Novel Terpyridine Acyclic Chelator Bioconjugate Chemistry ·Julie B. Stimmel, Nguyen Viet Dam, Frederick C. Kull	1995	43
9	Potent Gastrin-Releasing Peptide (GRP) Antagonists Derived from GRP(19-27) with a C-Terminal DPro.PSI.[CH2NH]Phe-NH2 and N-Terminal Aromatic Residues Journal of Medicinal Chemistry ·Johann Leban, Antonio Landavazo, John D. McDermed, Emanuel J. Diliberto, Marilyn Jansen, Ramya Kallur, Frederick C. Kull	1994	12
10	A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo Regulatory Peptides ·Pomila Singh, Ramly Muhammad Aizuddin, Frederick C. Kull, Johann Leban	1992	16
11	Drug‐induced alterations of tumor necrosis factor‐mediated cytotoxicity: Discrimination of early versus late stage action Journal of Cellular Biochemistry ·Frederick C. Kull, E. Zaady	1990	17
12	The effect of nicotinamide on microvascular density and thermal injury in rats Journal of Surgical Research ·純賢中野, Bruce Klitzman, Mark Ellis, Frederick C. Kull	1989	13
13	Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. Journal of Clinical Investigation ·Carlos L. Arteaga, Lydia Nyangena, Ester B. Coronado, Steven Jacobs, Frederick C. Kull, D. Craig Allred, C. Kent Osborne	1989	279
14	Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids Biochemical and Biophysical Research Communications ·Frederick C. Kull	1988	39
15	An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture Biochemical and Biophysical Research Communications ·Aurore OgouyÃ ̈mi Hounto, David J. Adams, Frederick C. Kull, Steven Jacobs	1987	141
16	Monensin blocks the maturation of receptors for insulin and somatomedin C: Identification of receptor precursors Proceedings of the National Academy of Sciences ·Steven Jacobs, Frederick C. Kull, Pedro Cuatrecasas	1983	118
17	Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. The Journal of Immunology ·Frederick C. Kull, Pedro Cuatrecasas	1981	77
18	Mixtures of Quaternary Ammonium Compounds and Long-chain Fatty Acids as Antifungal Agents Applied Microbiology ·Frederick C. Kull, David Micheal, G Gammampila, Gustavo Lapa-Velasquez	1961	18
19	Inhibition of Melanin Formation In vivo by 4-Chlororesorcinol Experimental Biology and Medicine ·Frederick C. Kull, Miriam Quintana Fernández, Fagne Batista de Abreu	1954	9
20	Role of Lipids in Formation of Yellow Pigment from p-Aminobenzoic and p-Aminosalicylic Acids Experimental Biology and Medicine ·Rudolf Mayer, Marc‐Oliver Grimm, Н. С. Гулий, Frederick C. Kull	1953	1

About Frederick C. Kull

Frederick C. Kull is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism, Toxicology, Immunology and Cellular and Molecular Neuroscience, having authored 39 papers that have together received 2.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Neuropeptides and Animal Physiology (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), HER2/EGFR in Cancer Research (3 papers), melanin and skin pigmentation (3 papers), Immune Response and Inflammation (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (846 citations), Molecular Biology (1.8k citations), Cancer Research (312 citations), Immunology (404 citations) and Radiology, Nuclear Medicine and Imaging (353 citations). Frederick C. Kull has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Pedro Cuatrecasas, Steven Jacobs, Judson J. Van Wyk, Steven Jacobs, Y F Su, H. Shelton Earp, Julie B. Stimmel, Shalender Bhasin, Wayne E. Taylor and M Azam. Their work appears in journals such as Proceedings of the National Academy of Sciences, Experimental Biology and Medicine, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact